High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.

Kalniete, Dagnija; Nakazawa-Miklasevica, Miki; Strumfa, Ilze; Abolins, Arnis; Irmejs, Arvids; Gardovskis, Janis; Miklasevics, Edvins.

Afiliação

Kalniete D; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.
Nakazawa-Miklasevica M; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.
Strumfa I; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.
Abolins A; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.
Irmejs A; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia ; Breast Disease Center, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, LV-1002 Latvia.
Gardovskis J; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.
Miklasevics E; Institute of Oncology, Riga Stradins University, Dzirciema Street 16, Riga, LV-1007 Latvia.

Hered Cancer Clin Pract ; 13(1): 7, 2015.

Article em En | MEDLINE | ID: mdl-25705321